{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:36:01Z","timestamp":1794839761274,"version":"4.9.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The function of islet macrophages is poorly understood. They promote glucose-stimulated insulin secretion (GSIS) in lean mice, however, the underlying mechanism has remained unclear. We show that activation of the free fatty acid receptor FFAR4 on islet macrophages leads to interleukin-6 (IL-6) release and that IL-6 promotes \u03b2-cell function. This mechanism is required for GSIS in lean male mice, but does not function anymore in islets from people with obesity and obese type 2 diabetic male mice. In islets from obese mice, FFAR4 downstream signaling in macrophages is strongly reduced, resulting in impaired FFAR4-mediated IL-6 release. However, IL-6 treatment can still improve GSIS in islets from people with obesity and obese type 2 diabetic mice. These data show that a defect in FFAR4-mediated macrophage activation contributes to reduced GSIS in type 2 diabetes and suggest that reactivating islet macrophage FFAR4 and promoting or mimicking IL-6 release from islet macrophages improves GSIS in type 2 diabetes.<\/jats:p>","DOI":"10.1038\/s41467-025-58706-5","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T15:41:39Z","timestamp":1744299699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["FFAR4-mediated IL-6 release from islet macrophages promotes insulin secretion and is compromised in type-2 diabetes"],"prefix":"10.1038","volume":"16","author":[{"given":"Xinyi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5305-2344","authenticated-orcid":false,"given":"Jingchen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabell","family":"Brandenburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hahnefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7389-4282","authenticated-orcid":false,"given":"R\u00e9my","family":"Bonnavion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haaglim","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-1821","authenticated-orcid":false,"given":"ShengPeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6858-1460","authenticated-orcid":false,"given":"Nina","family":"Wettschureck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gurke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0490-466X","authenticated-orcid":false,"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-6805","authenticated-orcid":false,"given":"Stefan","family":"Offermanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"58706_CR1","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen, M. C. & Shulman, G. I. Mechanisms of insulin action and insulin resistance. Physiol. Rev. 98, 2133\u20132223 (2018).","journal-title":"Physiol. Rev."},{"key":"58706_CR2","doi-asserted-by":"publisher","first-page":"101304","DOI":"10.1016\/j.molmet.2021.101304","volume":"52","author":"MF White","year":"2021","unstructured":"White, M. F. & Kahn, C. R. Insulin action at a molecular level \u2212 100 years of progress. Mol. Metab. 52, 101304 (2021).","journal-title":"Mol. Metab."},{"key":"58706_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev-physiol-030212-183754","volume":"75","author":"P Rorsman","year":"2013","unstructured":"Rorsman, P. & Braun, M. Regulation of insulin secretion in human pancreatic islets. Annu. Rev. Physiol 75, 155\u2013179 (2013).","journal-title":"Annu. Rev. Physiol"},{"key":"58706_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41580-020-00317-7","volume":"22","author":"JE Campbell","year":"2021","unstructured":"Campbell, J. E. & Newgard, C. B. Mechanisms controlling pancreatic islet cell function in insulin secretion. Nat. Rev. Mol. Cell Biol. 22, 142\u2013158 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"58706_CR5","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1210\/me.2012-1101","volume":"26","author":"N Simpson","year":"2012","unstructured":"Simpson, N. et al. Dopamine-mediated autocrine inhibitory circuit regulating human insulin secretion in vitro. Mol. Endocrinol. 26, 1757\u20131772 (2012).","journal-title":"Mol. Endocrinol."},{"key":"58706_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nm.3779","volume":"21","author":"C Tang","year":"2015","unstructured":"Tang, C. et al. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat. Med. 21, 173\u2013177 (2015).","journal-title":"Nat. Med."},{"key":"58706_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02539-4","volume":"9","author":"S Tunaru","year":"2018","unstructured":"Tunaru, S. et al. 20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1. Nat. Commun. 9, 177 (2018).","journal-title":"Nat. Commun."},{"key":"58706_CR8","doi-asserted-by":"publisher","first-page":"6465","DOI":"10.1073\/pnas.0908935107","volume":"107","author":"MC Jacques-Silva","year":"2010","unstructured":"Jacques-Silva, M. C. et al. ATP-gated P2X3 receptors constitute a positive autocrine signal for insulin release in the human pancreatic beta cell. Proc. Natl. Acad. Sci. USA 107, 6465\u20136470 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58706_CR9","doi-asserted-by":"publisher","first-page":"36824","DOI":"10.1074\/jbc.M505560200","volume":"280","author":"B Rubi","year":"2005","unstructured":"Rubi, B. et al. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J. Biol. Chem. 280, 36824\u201336832 (2005).","journal-title":"J. Biol. Chem."},{"key":"58706_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrd2782","volume":"8","author":"B Ahren","year":"2009","unstructured":"Ahren, B. Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes. Nat. Rev. Drug. Discov. 8, 369\u2013385 (2009).","journal-title":"Nat. Rev. Drug. Discov."},{"key":"58706_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.tips.2017.06.006","volume":"38","author":"G Milligan","year":"2017","unstructured":"Milligan, G., Alvarez-Curto, E., Hudson, B. D., Prihandoko, R. & Tobin, A. B. FFA4\/GPR120: Pharmacology and therapeutic opportunities. Trends Pharmacol. Sci. 38, 809\u2013821 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"58706_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cmet.2017.03.008","volume":"25","author":"AS Husted","year":"2017","unstructured":"Husted, A. S., Trauelsen, M., Rudenko, O., Hjorth, S. A. & Schwartz, T. W. GPCR-Mediated signaling of metabolites. Cell Metab. 25, 777\u2013796 (2017).","journal-title":"Cell Metab."},{"key":"58706_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1146\/annurev-pharmtox-011613-135945","volume":"54","author":"S Offermanns","year":"2014","unstructured":"Offermanns, S. Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors. Annu. Rev. Pharmacol. Toxicol. 54, 407\u2013434 (2014).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"58706_CR14","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41574-020-00459-w","volume":"17","author":"J Ghislain","year":"2021","unstructured":"Ghislain, J. & Poitout, V. Targeting lipid GPCRs to treat type 2 diabetes mellitus - progress and challenges. Nat. Rev. Endocrinol. 17, 162\u2013175 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"58706_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-nutr-071714-034410","volume":"35","author":"T Ulven","year":"2015","unstructured":"Ulven, T. & Christiansen, E. Dietary fatty acids and their potential for controlling metabolic diseases through activation of FFA4\/GPR120. Annu. Rev. Nutr. 35, 239\u2013263 (2015).","journal-title":"Annu. Rev. Nutr."},{"key":"58706_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature01478","volume":"422","author":"Y Itoh","year":"2003","unstructured":"Itoh, Y. et al. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 422, 173\u2013176 (2003).","journal-title":"Nature"},{"key":"58706_CR17","doi-asserted-by":"publisher","first-page":"15751","DOI":"10.1074\/jbc.M114.568683","volume":"289","author":"AT Suckow","year":"2014","unstructured":"Suckow, A. T. et al. Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion. J. Biol. Chem. 289, 15751\u201315763 (2014).","journal-title":"J. Biol. Chem."},{"key":"58706_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/CS20180836","volume":"133","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Xie, T., Zhang, D. & Leung, P. S. GPR120 protects lipotoxicity-induced pancreatic beta-cell dysfunction through regulation of PDX1 expression and inhibition of islet inflammation. Clin. Sci. 133, 101\u2013116 (2019).","journal-title":"Clin. Sci."},{"key":"58706_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.cell.2010.07.041","volume":"142","author":"DY Oh","year":"2010","unstructured":"Oh, D. Y. et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687\u2013698 (2010).","journal-title":"Cell"},{"key":"58706_CR20","doi-asserted-by":"publisher","unstructured":"Croze, M. L. et al. Combined deletion of free fatty-acid receptors 1 and 4 minimally impacts glucose homeostasis in mice. Endocrinology 162, https:\/\/doi.org\/10.1210\/endocr\/bqab002 (2021).","DOI":"10.1210\/endocr\/bqab002"},{"key":"58706_CR21","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature10798","volume":"483","author":"A Ichimura","year":"2012","unstructured":"Ichimura, A. et al. Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350\u2013354 (2012).","journal-title":"Nature"},{"key":"58706_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm.3614","volume":"20","author":"DY Oh","year":"2014","unstructured":"Oh, D. Y. et al. A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice. Nat. Med. 20, 942\u2013947 (2014).","journal-title":"Nat. Med."},{"key":"58706_CR23","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1007\/s00125-014-3213-0","volume":"57","author":"VM Stone","year":"2014","unstructured":"Stone, V. M. et al. GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans. Diabetologia 57, 1182\u20131191 (2014).","journal-title":"Diabetologia"},{"key":"58706_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101166","volume":"45","author":"ML Croze","year":"2021","unstructured":"Croze, M. L. et al. Free fatty acid receptor 4 inhibitory signaling in delta cells regulates islet hormone secretion in mice. Mol. Metab. 45, 101166 (2021).","journal-title":"Mol. Metab."},{"key":"58706_CR25","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/dom.12330","volume":"16","author":"BM Moran","year":"2014","unstructured":"Moran, B. M., Abdel-Wahab, Y. H., Flatt, P. R. & McKillop, A. M. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic beta-cells. Diabetes Obes. Metab. 16, 1128\u20131139 (2014).","journal-title":"Diabetes Obes. Metab."},{"key":"58706_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/CS20160545","volume":"131","author":"D Zhang","year":"2017","unstructured":"Zhang, D. et al. Insulinotropic effects of GPR120 agonists are altered in obese diabetic and obese non-diabetic states. Clin. Sci. 131, 247\u2013260 (2017).","journal-title":"Clin. Sci."},{"key":"58706_CR27","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1101\/gad.348261.121","volume":"35","author":"CT Wu","year":"2021","unstructured":"Wu, C. T. et al. Discovery of ciliary G protein-coupled receptors regulating pancreatic islet insulin and glucagon secretion. Genes Dev. 35, 1243\u20131255 (2021).","journal-title":"Genes Dev."},{"key":"58706_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jim.2016.04.004","volume":"434","author":"J Loschko","year":"2016","unstructured":"Loschko, J. et al. Inducible targeting of cDCs and their subsets in vivo. J. Immunol. Methods 434, 32\u201338 (2016).","journal-title":"J. Immunol. Methods"},{"key":"58706_CR29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/dvg.20335","volume":"45","author":"MD Muzumdar","year":"2007","unstructured":"Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. & Luo, L. A global double-fluorescent Cre reporter mouse. Genesis 45, 593\u2013605 (2007).","journal-title":"Genesis"},{"key":"58706_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.109540","volume":"27","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Islet-resident macrophage-derived miR-155 promotes beta cell decompensation via targeting PDX1. iScience 27, 109540 (2024).","journal-title":"iScience"},{"key":"58706_CR31","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1084\/jem.20062648","volume":"204","author":"ML Caton","year":"2007","unstructured":"Caton, M. L., Smith-Raska, M. R. & Reizis, B. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J. Exp. Med. 204, 1653\u20131664 (2007).","journal-title":"J. Exp. Med."},{"key":"58706_CR32","doi-asserted-by":"publisher","first-page":"13163","DOI":"10.1073\/pnas.0801059105","volume":"105","author":"H Ellingsgaard","year":"2008","unstructured":"Ellingsgaard, H. et al. Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc. Natl. Acad. Sci. USA 105, 13163\u201313168 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58706_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41586-018-0590-4","volume":"562","author":"Tabula Muris Consortium, e. t. c.","year":"2018","unstructured":"Tabula Muris Consortium, e. t. c. Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature 562, 367\u2013372 (2018).","journal-title":"Nature"},{"key":"58706_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/08916939009002977","volume":"5","author":"K Buschard","year":"1990","unstructured":"Buschard, K., Aaen, K., Horn, T., Van Damme, J. & Bendtzen, K. Interleukin 6: a functional and structural in vitro modulator of beta-cells from islets of Langerhans. Autoimmunity 5, 185\u2013194 (1990).","journal-title":"Autoimmunity"},{"key":"58706_CR35","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1530\/JOE-12-0223","volume":"214","author":"M da Silva Krause","year":"2012","unstructured":"da Silva Krause, M. et al. Physiological concentrations of interleukin-6 directly promote insulin secretion, signal transduction, nitric oxide release, and redox status in a clonal pancreatic beta-cell line and mouse islets. J Endocrinol 214, 301\u2013311 (2012).","journal-title":"J Endocrinol"},{"key":"58706_CR36","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2337\/db10-0796","volume":"60","author":"T Suzuki","year":"2011","unstructured":"Suzuki, T. et al. Interleukin-6 enhances glucose-stimulated insulin secretion from pancreatic beta-cells: potential involvement of the PLC-IP3-dependent pathway. Diabetes 60, 537\u2013547 (2011).","journal-title":"Diabetes"},{"key":"58706_CR37","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.2337\/db06-1650","volume":"56","author":"JA Ehses","year":"2007","unstructured":"Ehses, J. A. et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56, 2356\u20132370 (2007).","journal-title":"Diabetes"},{"key":"58706_CR38","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1073\/pnas.81.13.4174","volume":"81","author":"DA Hume","year":"1984","unstructured":"Hume, D. A., Halpin, D., Charlton, H. & Gordon, S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4\/80: macrophages of endocrine organs. Proc. Natl. Acad. Sci. USA 81, 4174\u20134177 (1984).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58706_CR39","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1084\/jem.20150496","volume":"212","author":"B Calderon","year":"2015","unstructured":"Calderon, B. et al. The pancreas anatomy conditions the origin and properties of resident macrophages. J. Exp. Med. 212, 1497\u20131512 (2015).","journal-title":"J. Exp. Med."},{"key":"58706_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cmet.2018.12.003","volume":"29","author":"W Ying","year":"2019","unstructured":"Ying, W. et al. Expansion of islet-resident macrophages leads to inflammation affecting beta cell proliferation and function in obesity. Cell Metab. 29, 457\u2013474 (2019).","journal-title":"Cell Metab."},{"key":"58706_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41574-019-0286-3","volume":"16","author":"W Ying","year":"2020","unstructured":"Ying, W., Fu, W., Lee, Y. S. & Olefsky, J. M. The role of macrophages in obesity-associated islet inflammation and beta-cell abnormalities. Nat. Rev. Endocrinol. 16, 81\u201390 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"key":"58706_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/164_2021_571","volume":"274","author":"J Cuenco","year":"2022","unstructured":"Cuenco, J. & Dalmas, E. Islet inflammation and beta cell dysfunction in type 2 diabetes. Handb. Exp. Pharmacol. 274, 227\u2013251 (2022).","journal-title":"Handb. Exp. Pharmacol."},{"key":"58706_CR43","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1007\/s00125-023-06007-1","volume":"66","author":"AJT Bosch","year":"2023","unstructured":"Bosch, A. J. T. et al. CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice. Diabetologia 66, 2292\u20132306 (2023).","journal-title":"Diabetologia"},{"key":"58706_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ni.3659","volume":"18","author":"E Dror","year":"2017","unstructured":"Dror, E. et al. Postprandial macrophage-derived IL-1beta stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat. Immunol. 18, 283\u2013292 (2017).","journal-title":"Nat. Immunol."},{"key":"58706_CR45","first-page":"E19","volume":"256","author":"WS Zawalich","year":"1989","unstructured":"Zawalich, W. S. & Zawalich, K. C. Interleukin 1 is a potent stimulator of islet insulin secretion and phosphoinositide hydrolysis. Am. J. Physiol. 256, E19\u201324 (1989).","journal-title":"Am. J. Physiol."},{"key":"58706_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.molmet.2018.06.003","volume":"14","author":"SJ Burke","year":"2018","unstructured":"Burke, S. J. et al. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet beta-cell de-differentiation. Mol. Metab. 14, 95\u2013107 (2018).","journal-title":"Mol. Metab."},{"key":"58706_CR47","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86055","volume":"1","author":"C Hajmrle","year":"2016","unstructured":"Hajmrle, C. et al. Interleukin-1 signaling contributes to acute islet compensation. JCI Insight 1, e86055 (2016).","journal-title":"JCI Insight"},{"key":"58706_CR48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00125-017-4416-y","volume":"61","author":"JR Weitz","year":"2018","unstructured":"Weitz, J. R. et al. Mouse pancreatic islet macrophages use locally released ATP to monitor beta cell activity. Diabetologia 61, 182\u2013192 (2018).","journal-title":"Diabetologia"},{"key":"58706_CR49","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2337\/db19-0687","volume":"69","author":"JR Weitz","year":"2020","unstructured":"Weitz, J. R. et al. Secretory Functions of Macrophages in the Human Pancreatic Islet Are Regulated by Endogenous Purinergic Signaling. Diabetes 69, 1206\u20131218 (2020).","journal-title":"Diabetes"},{"key":"58706_CR50","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448\u2013457 (2015).","journal-title":"Nat. Immunol."},{"key":"58706_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/1744666X.2022.2045952","volume":"18","author":"FF Kreiner","year":"2022","unstructured":"Kreiner, F. F., Kraaijenhof, J. M., von Herrath, M., Hovingh, G. K. K. & von Scholten, B. J. Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: mechanisms and therapeutic perspectives. Expert Rev. Clin. Immunol. 18, 377\u2013389 (2022).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"58706_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.it.2014.12.008","volume":"36","author":"J Mauer","year":"2015","unstructured":"Mauer, J., Denson, J. L. & Bruning, J. C. Versatile functions for IL-6 in metabolism and cancer. Trends Immunol. 36, 92\u2013101 (2015).","journal-title":"Trends Immunol."},{"key":"58706_CR53","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00592-015-0807-z","volume":"53","author":"M Dauriz","year":"2016","unstructured":"Dauriz, M. et al. Interleukin-6 as a potential positive modulator of human beta-cell function: an exploratory analysis-the Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 6. Acta Diabetol. 53, 393\u2013402 (2016).","journal-title":"Acta Diabetol."},{"key":"58706_CR54","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1096\/fj.201700061RR","volume":"31","author":"AK Linnemann","year":"2017","unstructured":"Linnemann, A. K. et al. Interleukin 6 protects pancreatic beta cells from apoptosis by stimulation of autophagy. FASEB J. 31, 4140\u20134152 (2017).","journal-title":"FASEB J."},{"key":"58706_CR55","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.2337\/db17-1280","volume":"67","author":"MR Marasco","year":"2018","unstructured":"Marasco, M. R. et al. Interleukin-6 Reduces beta-Cell Oxidative Stress by Linking Autophagy With the Antioxidant Response. Diabetes 67, 1576\u20131588 (2018).","journal-title":"Diabetes"},{"key":"58706_CR56","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cmet.2012.04.009","volume":"15","author":"DY Oh","year":"2012","unstructured":"Oh, D. Y. & Olefsky, J. M. Omega 3 fatty acids and GPR120. Cell Metab. 15, 564\u2013565 (2012).","journal-title":"Cell Metab."},{"key":"58706_CR57","doi-asserted-by":"publisher","first-page":"e114942","DOI":"10.1371\/journal.pone.0114942","volume":"9","author":"M Bjursell","year":"2014","unstructured":"Bjursell, M. et al. The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120. PLoS ONE 9, e114942 (2014).","journal-title":"PLoS ONE"},{"key":"58706_CR58","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1536047","volume":"2016","author":"SI Paerregaard","year":"2016","unstructured":"Paerregaard, S. I. et al. FFAR4 (GPR120) Signaling Is Not Required for Anti-Inflammatory and Insulin-Sensitizing Effects of Omega-3 Fatty Acids. Mediators Inflamm. 2016, 1536047 (2016).","journal-title":"Mediators Inflamm."},{"key":"58706_CR59","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1021\/acs.chemrev.6b00056","volume":"117","author":"G Milligan","year":"2017","unstructured":"Milligan, G., Shimpukade, B., Ulven, T. & Hudson, B. D. Complex pharmacology of free fatty acid receptors. Chem. Rev. 117, 67\u2013110 (2017).","journal-title":"Chem. Rev."},{"key":"58706_CR60","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1079\/PNS19970071","volume":"56","author":"KN Frayn","year":"1997","unstructured":"Frayn, K. N., Summers, L. K. & Fielding, B. A. Regulation of the plasma non-esterified fatty acid concentration in the postprandial state. Proc. Nutr. Soc. 56, 713\u2013721 (1997).","journal-title":"Proc. Nutr. Soc."},{"key":"58706_CR61","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s42255-023-00899-4","volume":"5","author":"JL Wang","year":"2023","unstructured":"Wang, J. L. et al. Functional screening and rational design of compounds targeting GPR132 to treat diabetes. Nat. Metab. 5, 1726\u20131746 (2023).","journal-title":"Nat. Metab."},{"key":"58706_CR62","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1124\/mol.113.087783","volume":"84","author":"BD Hudson","year":"2013","unstructured":"Hudson, B. D. et al. The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4\/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Mol. Pharmacol. 84, 710\u2013725 (2013).","journal-title":"Mol. Pharmacol."},{"key":"58706_CR63","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJM196304042681404","volume":"268","author":"LH Opie","year":"1963","unstructured":"Opie, L. H. & Walfish, P. G. Plasma free fatty acid concentrations in obesity. N. Engl. J. Med. 268, 757\u2013760 (1963).","journal-title":"N. Engl. J. Med."},{"key":"58706_CR64","doi-asserted-by":"publisher","first-page":"165360","DOI":"10.1155\/2008\/165360","volume":"2008","author":"MJ Smelt","year":"2008","unstructured":"Smelt, M. J., Faas, M. M., de Haan, B. J. & de Vos, P. Pancreatic beta-cell purification by altering FAD and NAD(P)H metabolism. Exp. Diabetes Res. 2008, 165360 (2008).","journal-title":"Exp. Diabetes Res."},{"key":"58706_CR65","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1463-1326.2008.00947.x","volume":"10","author":"C Hinault","year":"2008","unstructured":"Hinault, C., Hu, J., Maier, B. F., Mirmira, R. G. & Kulkarni, R. N. Differential expression of cell cycle proteins during ageing of pancreatic islet cells. Diabetes Obes. Metab. 10, 136\u2013146 (2008).","journal-title":"Diabetes Obes. Metab."},{"key":"58706_CR66","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1093\/emboj\/17.15.4304","volume":"17","author":"S Offermanns","year":"1998","unstructured":"Offermanns, S. et al. Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q\/G alpha 11-mutant mice. EMBO J. 17, 4304\u20134312 (1998).","journal-title":"EMBO J."},{"key":"58706_CR67","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/nm1101-1236","volume":"7","author":"N Wettschureck","year":"2001","unstructured":"Wettschureck, N. et al. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq\/Galpha11 in cardiomyocytes. Nat Med 7, 1236\u20131240 (2001).","journal-title":"Nat Med"},{"key":"58706_CR68","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bbi.2012.10.011","volume":"27","author":"A Quintana","year":"2013","unstructured":"Quintana, A. et al. Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior. Brain Behav. Immun. 27, 162\u2013173 (2013).","journal-title":"Brain Behav. Immun."},{"key":"58706_CR69","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.celrep.2014.11.033","volume":"9","author":"J Piccand","year":"2014","unstructured":"Piccand, J. et al. Rfx6 maintains the functional identity of adult pancreatic beta cells. Cell Rep. 9, 2219\u20132232 (2014).","journal-title":"Cell Rep."},{"key":"58706_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jmsacl.2023.02.002","volume":"28","author":"A Sens","year":"2023","unstructured":"Sens, A. et al. Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research. J. Mass Spectrom. Adv. Clin. Lab 28, 35\u201346 (2023).","journal-title":"J. Mass Spectrom. Adv. Clin. Lab"},{"key":"58706_CR71","doi-asserted-by":"publisher","first-page":"D640","DOI":"10.1093\/nar\/gkad1045","volume":"52","author":"O Yurekten","year":"2024","unstructured":"Yurekten, O. et al. MetaboLights: open data repository for metabolomics. Nucleic Acids Res. 52, D640\u2013D646 (2024).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58706-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58706-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T17:04:46Z","timestamp":1744304686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58706-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58706"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58706-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"2 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3422"}}